Mates Sharon

CIK 00015856992 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001585699

Recent Transactions

50 trades

Award
Benitec Biopharma Inc.$BNTC
Options (right to buy)
2025-12-01+3,500→ 3,500 total
Award
Benitec Biopharma Inc.$BNTC
Options (right to buy)
2025-11-05+28,517→ 28,517 total
Award
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02+34,970→ 34,970 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02−40,712→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Common Stock
2025-04-02$132.00/sh−190,000→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−86,003→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−66,886→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−135,399→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−40,713→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−69,940→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−50,167→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−121,212→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02−34,970→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−138,473→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−53,471→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Common Stock
2025-04-02$132.00/sh−945,235→ 0 total
Award
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02+40,712→ 40,712 total
Gift
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-26+190,000→ 190,000 total
Gift
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-26−190,000→ 945,235 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-10$131.24/sh−10,129→ 1,135,235 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-10+20,566→ 1,145,364 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-10−20,566→ 0 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-06$131.19/sh−19,848→ 1,124,798 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-06+40,712→ 1,144,646 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-06−40,712→ 40,713 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-01$128.20/sh−16,978→ 1,103,934 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-01−34,969→ 69,940 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-01+34,969→ 1,120,912 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-02-03+121,212→ 121,212 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2025-01-31+30,847→ 1,101,176 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-01-31$127.00/sh−15,233→ 1,085,943 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-12-05$12.73/sh+51,697→ 1,122,026 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-12-05−51,697→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-12-05$84.06/sh−50,163→ 1,071,863 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-12-05$84.69/sh−1,534→ 1,070,329 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-12-04−51,000→ 51,697 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-12-04$86.00/sh−23,333→ 1,070,329 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-12-04$12.73/sh+51,000→ 1,121,329 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-12-04$85.62/sh−27,667→ 1,093,662 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-08-30$73.32/sh−6,193→ 1,070,329 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-08-30$12.73/sh+34,396→ 1,104,725 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-08-30$72.73/sh−28,203→ 1,076,522 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-08-30−34,396→ 102,697 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-08-29$12.73/sh+35,604→ 1,105,933 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-08-29−35,604→ 137,093 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-08-29$73.25/sh−5,772→ 1,070,329 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-08-29$72.44/sh−29,832→ 1,076,101 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-08-28$17.57/sh+32,699→ 1,103,028 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-08-28−32,699→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-08-28$73.70/sh−240→ 1,070,329 total

Companies

Recent Filings

Address

C/O INTRA-CELLULAR THERAPIES, INC. 3960 BROADWAY

NEW YORK, NY, 10032

View on SEC.gov